Chronos Wealth Management, LLC Eli Lilly & CO Transaction History

Chronos Wealth Management, LLC

$192 Million
Q3 2024

A detailed history of Chronos Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chronos Wealth Management, LLC holds 23,220 shares of LLY stock, worth $17.4 Million. This represents 10.73% of its overall portfolio holdings.

Number of Shares

23,220

Previous 23,572 1.49%

Holding current value

$17.4 Million

Previous $21.3 Million 3.61%

% of portfolio

10.73%

Previous 11.87%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$772.14 - $960.02 $271,793 - $337,927	-352 Reduced 1.49%	23,220 $20.6 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $453,768 - $569,059	-626 Reduced 2.59%	23,572 $21.3 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $475,536 - $636,200	-803 Reduced 3.21%	24,198 $18.8 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $1.01 Million - $1.19 Million	-1,918 Reduced 7.13%	25,001 $14.6 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $171,271 - $236,124	-394 Reduced 1.44%	26,919 $14.5 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $325,135 - $434,744	-927 Reduced 3.28%	27,313 $12.8 Million
Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $91,946 - $107,986	-296 Reduced 1.04%	28,240 $9.7 Million
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $380,393 - $443,234	-1,183 Reduced 3.98%	28,536 $0
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $390,167 - $444,636	-1,316 Reduced 4.24%	29,719 $9.61 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $1.57 Million - $1.84 Million	-5,636 Reduced 15.37%	31,035 $10.1 Million
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $101,386 - $125,997	-432 Reduced 1.16%	36,671 $10.5 Million
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $50,591 - $62,784	-225 Reduced 0.6%	37,103 $10.2 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $111,464 - $137,173	-503 Reduced 1.33%	37,328 $8.63 Million
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $70,414 - $91,080	390 Added 1.04%	37,831 $8.68 Million
Q1 2021 Apr 13, 2021	BUY	$164.32 - $212.72 $61,455 - $79,557	374 Added 1.01%	37,441 $7 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $49,052 - $64,908	376 Added 1.02%	37,067 $6.26 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $1.13 Million - $1.31 Million	7,719 Added 26.64%	36,691 $5.43 Million
Q2 2020 Jul 24, 2020	BUY	$136.42 - $164.18 $625,894 - $753,257	4,588 Added 18.82%	28,972 $4.76 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $515,248 - $637,730	4,328 Added 21.58%	24,384 $3.38 Million
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $2.14 Million - $2.66 Million	20,056 New	20,056 $2.64 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chronos Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chronos Wealth Management, LLC with notifications on news.

Account

Chronos Wealth Management, LLC Eli Lilly & CO Transaction History